Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Scott Davis

Melius Research · covers Industrials, Basic Materials, Healthcare, Technology

Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q2 (8 quarters).

Questions
186on tracked calls
Challenge rate
5%9 of 186 questions
Companies
19questioned at least once
Reporting periods
8with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 186 of 186 questions from 19 companies

ROKRockwell Automation15 questions · 8 reporting periods · 0 of 15 challenging
ROK company page →

Calendar 2026 Q2

I haven't heard you mention Plex in a while. Where are we on the deal model on that asset?

Show response

Moret said Plex sits in the high-single-digit software ARR, keeps adding new logos in automotive and consumer, and is embedding agentic AI across its modules.

Are the tariff price increases actually separate and they come off as soon as tariffs come up?

PricingTrade TariffsTranscript · FY2026 Q3 →
Show response

Rothe walked through the 250 bps full-year price target, splitting it into 100 bps tariff-based and 150 bps underlying, and framed tariff pricing as EPS-neutral, not incremental.

Calendar 2026 Q1

What does that mean as it relates to kind of content intensity and differences? I mean, how meaningful is that change for Rockwell?

DemandCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Blake clarified same products are used in modernization as in greenfield, with slightly less Lifecycle Services involvement. Content per project remains similar.

are you comfortable sizing it for us and helping us understand kind of what that TAM may look like for your products?

Cloud & AIRevenue GrowthDemandTranscript · FY2026 Q2 →
Show response

Blake acknowledged data center is still low single digits of sales but declined to size it precisely, saying they'll evaluate at year-end.

Calendar 2025 Q4

are the distributors still a little bit cautious and not restocking yet?

Show response

Blake confirmed distributor inventory levels back to normal worldwide. Distributor destock dialogue from 2024/early 2025 is done. Distributors are optimistic but taking a prudent approach.

just maybe a little bit more detail. Do you think people will underspend their budgets, or are they just pushing back to the back half of the year?

Capex InvestmentDemandTranscript · FY2026 Q1 →
Show response

Blake cited optimism in certain areas contributing to strong Q1 but hasn't seen broad-based release of orders needed to center on higher end of guide. Wants more evidence before moving up.

Calendar 2025 Q3

is getting Process up to Discrete margins something that is more a function of volumes?

MarginCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

Blake acknowledged structural margin gap from engineering-intensive process work but highlighted Lifecycle Services margin improvements, AI-enabled software-defined automation reducing integration costs, and rigorous project selection.

what was kind of the postmortem of why it didn't work out?

Capital AllocationCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

Blake cited COVID timing, broad scope adding costs, and Rockwell's own technology evolution since 2019 making a JV less necessary. Jointly decided it wouldn't meet long-term goals.

Calendar 2025 Q2

are you behind the investment curve and you have to catch up. The other is, are you playing offense? So how do you guys look at it?

Capex InvestmentMarginTranscript · FY2025 Q3 →
Show response

Blake framed the $2B investment as offensive, building on productivity momentum. Benefits already seen in plants: labor productivity, energy consumption, faster time to confidence. Christian noted not all $2B is incremental, includes existing run rate, and all projects are ROI-based with double-digit hurdle rates.

Calendar 2025 Q1

how big of a deal are the tariff -- I mean so many of those guys are in Europe or even Canada coming down into the US

Trade TariffsCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Blake differentiated: China-made machines face prohibitive tariffs, European machine builders have more flexibility with US locations and targeted pricing. Rockwell has considerable manufacturing flexibility.

What are your customers -- I know you're selling to a lot of different end markets, but so maybe perhaps more -- a little bit more discrete and hybrid focused here

Capex InvestmentTrade TariffsTranscript · FY2025 Q2 →
Show response

Blake categorized delay reasons: cost certainty concerns from tariffs, demand concerns from lower commodities, CHIPS Act funding uncertainty, and general risk/T&C concerns. Positives: e-commerce growth, packaging green shoots, and life sciences announcements.

Calendar 2024 Q4

21,000 sounds like a lot. I know you sell a lot of stuff, so maybe it's not. But in context, it sounds like a lot

Cost PressureMarginTranscript · FY2025 Q1 →
Show response

Christian explained these were heavily no-sales and low-sales SKUs with no material revenue or margin impact in FY2025. Another 39,000 SKUs under review for further action.

would you expect that there's a little bit of a positive bias to that guidance? Is that fair to say?

Guidance ReliabilityDemandTranscript · FY2025 Q1 →
Show response

Blake acknowledged the good start with better-than-expected orders but said it keeps the thesis intact and they need to see continued growth through the year.

Calendar 2024 Q3

you implied that maybe the election caused some noise. Do you see a restock happening imminently is that something that seems possible?

Show response

Blake stated they are not counting on rapid acceleration for distributors to put additional inventory back on shelves, though they are nearing the end of excess stock drain.

the last time we had tariffs come in, what were the customer responses? Were they more likely to pre-buy and kind of buildup in particular distributors, build up inventory?

Trade TariffsDemandTranscript · FY2024 Q4 →
Show response

Blake noted that unlike regular price increases, tariffs did not drive purchase acceleration. He expressed confidence in agility to get ahead of pricing if new tariffs come.

MMM3M Company14 questions · 7 reporting periods · 1 of 14 challenging
MMM company page →

Calendar 2026 Q2

Is there an opportunity for that to scale across more hyperscalers and how do you think about that?

Product LaunchCloud & AITranscript · FY2026 Q2 →
Show response

Bill sized current EBO revenue at $40-50M, said it could grow 4-5x or more, and noted 3M is in trials with other hyperscalers.

I'd kind of given up on China, but it sounds like China could potentially be a growth engine for you guys again.

Geographic ExpansionDemandTranscript · FY2026 Q2 →
Show response

Bill credited a China-based team, localized NPI, and commercial execution for double-digit growth and share gains.

Calendar 2026 Q1

you mentioned your factory footprint is down like 10%. Is there another 10%?

MarginCapex InvestmentTranscript · FY2026 Q1 →
Show response

Brown confirmed further reductions ahead but declined to quantify, saying they'll size it for investors over time.

Are customer inventories low and there's a little bit of a restock occurring? Or are they balanced?

Show response

Brown said Safety & Industrial channel inventory normal to slightly below 65-70 day norm; Consumer inventory normalized around 13 weeks.

Calendar 2025 Q4

just as we exited 2025, where is your sense of where your customer inventory levels were or are?

Show response

Bill said industrial channels normalized at ~60-day range with strong POS sell-through; consumer slightly elevated but improved in December.

what is the pricing strategy right now? I mean, it kind of when just listening to the prepared remarks

PricingRevenue GrowthTranscript · FY2025 Q4 →
Show response

Bill described three pricing levers: material inflation coverage, tighter governance, and new product value pricing; 80bps expected in 2026.

Calendar 2025 Q3

can 3M actually be a above -- historically, it's been kind of 2%, 3% growth company. Can it be a 4%, 5%, 6%

Revenue GrowthInnovation & R&DTranscript · FY2025 Q3 →
Show response

Bill said Class 4/5 products driving promising electrical growth; pipeline will shift more toward 4s and 5s into 2026/2027.

every CEO at 3M has talked about new products, but you seem to be delivering and actually getting results

Innovation & R&DProduct LaunchTranscript · FY2025 Q3 →
Show response

Bill cited pace, rigor, and urgency from teams, with R&D shift toward NPD (35-36% vs <30% prior) and innovation funnel of ~1,000 ideas.

Calendar 2025 Q2

I mean, historically, when you think about some of your customers have been tough to get price with auto

PricingCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Bill said industrial side is getting good price, auto is spec-in with embedded value, consumer big-box is harder, and MMM is covering inflation plus a bit for tariff impacts.

can you talk about the new product plan? And I guess, kind of more specifically teasing out

Innovation & R&DMarginTranscript · FY2025 Q2 →
Show response

Bill cited 5-year new product sales up 9% in H1 tracking to 15% FY, 70% more launches in Q2, R&D headcount +150, and expects margin benefit as new products stabilize and generate pricing.

Calendar 2025 Q1

3M is a global company, but it's a very American brand, at least that's the perception. Have you seen any

Geographic ExpansionCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

Bill said no observed anti-US purchasing behavior yet, citing strong global brands, 50 US factories, and large US supply base and R&D presence.

is just you feel like you're more or less exposed than your kind of average competitor to the tariff risk

Trade TariffsCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

Bill said exposure is mixed vs competitors; MMM has network flexibility advantage; walking from some private-label China-sourced consumer business, potentially gaining share; working with customers collaboratively on pricing.

Calendar 2024 Q4

in theory, if you had 100% on-time, in-full, would your growth rate be 100 basis points higher, 200 basis points higher?

ChallengingSupply ChainRevenue GrowthTranscript · FY2024 Q4 →
Show response

Bill said Consumer running 93% (needs high 90s), Transportation over 90%, SIBG in low 80s definitely losing business because customers buy elsewhere when product unavailable; fundamental top-line driver to fix supply chain.

perhaps you could just frame kind of what you're trying to change with the sales organization

Competitive DynamicsRevenue GrowthTranscript · FY2024 Q4 →
Show response

Bill said sales force getting quotas Jan 1 vs historical April rollout; more structure around sales manager cadence; six cross-sell pilots with distributors showed December momentum; working on pricing corridors and governance.

DDDuPont13 questions · 7 reporting periods · 0 of 13 challenging
DD company page →

Calendar 2026 Q2

can you talk about where you are today, kind of where you want to be and kind of a realistic time frame

MarginCost PressureTranscript · FY2026 Q2 →
Show response

Koch set the net productivity target at 3% of COGS annually, roughly 18 months to run-rate.

Calendar 2026 Q1

Where are we with stranded costs in the quarter and for the year

Cost PressureMarginTranscript · FY2026 Q1 →
Show response

Franzen confirmed $30M total stranded costs to be removed within 2 years. On track with ~$10M run rate reduction this year, halfway through total by year-end.

you guys have been implementing 80/20. Where are we in that process? And what kind of impact has that had on your top line?

MarginCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Koch confirmed 80/20 study 2/3 complete across 4 initial Diversified Industrial businesses. No impact baked into full year guidance on either top line or margin, but expect margin appreciation over time with minimal top line impact.

Calendar 2025 Q4

How do we cadence that into 2026? Is it more back-end loaded, or do you see real green shoots here early in the year

DemandMacroeconomicTranscript · FY2025 Q4 →
Show response

Koch outlined Shelter starting slightly negative in Q1 (tough two-year stack from -6% in 2025), then improving through the year to reach flat overall. Non-res and R&R up low single digits, resi down low to mid-single digits.

30% seems like a pretty robust number, but I don't really have any context to what that's been historically

Innovation & R&DPricingTranscript · FY2025 Q4 →
Show response

Koch explained vitality index (NPI sales as % of total) drives both revenue growth and margin uplift. New product margins higher than company average. 125 new products in 2025, working to shift mix from renewal/replacement toward growth-oriented launches.

Calendar 2025 Q3

can you just talk about what you're trying to achieve on that front? I don't have a great sense of where you are today and as it relates to lean

MarginCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Koch described enhanced management standards with 8 core KPIs (4 financial, 2 customer, 2 employee), monthly business reviews, and continuous improvement mindset building on existing OpEx framework.

what is kind of the plan and target there? And will there be -- I saw the buyback announcement, but will there be other deals like spectrum

Capital AllocationM&ATranscript · FY2025 Q3 →
Show response

Franzen outlined pro forma $3.25B debt, $1B cash, 1.7x leverage. $2B buyback authorization with imminent $500M ASR. Aramids proceeds coming Q1. ~$500M/year deployable free cash flow over next 3 years.

Calendar 2025 Q2

will there be an effort to capture price to offset the tariff impacts then as well

Trade TariffsPricingTranscript · FY2025 Q2 →
Show response

Koch noted supply chain moves drive most tariff mitigation, with only small surcharge component, not primarily pricing-driven.

The 1% price, would I assume that's mostly just due to the tieback weakness and some price you have to kind of give up in that business

Show response

Koch clarified pricing is in diversified industrials (not healthcare/water), a give-back from inflationary-era increases, expected to moderate as concessions lap.

Calendar 2025 Q1

I wanted just to see if you could give us the tariff numbers broken down into the two businesses

Show response

Franzen provided clear quantification: ~$30M net each for ElectronicsCo and IndustrialsCo, ~6% of COGS for both on gross basis.

would there be a long-term plan to try to locate that? In China, is there IP protections?

Trade TariffsSupply ChainTranscript · FY2025 Q1 →
Show response

Koch clarified the $200M was finished product exports while the $500M gross was intermediate product, with multiple levers still available.

Calendar 2024 Q4

can you size that for us at all? And kind of give us a sense of what kind of growth rates you've seen there?

Cloud & AIRevenue GrowthTranscript · FY2024 Q4 →
Show response

Koch provided specific dollar sizing ($300M+) and growth rate (30%), directly answering the question with quantitative detail.

how do you think about incrementals in 2025 and the sustainability kind of puts and takes of costs coming back?

MarginCost PressureTranscript · FY2024 Q4 →
Show response

Koch framed 2025 mid-40s incrementals as still strong, noted price/inflation net neutral on bottom line, deferred detailed margin targets to fall Investor Day.

DHRDanaher Corporation13 questions · 7 reporting periods · 0 of 13 challenging
DHR company page →

Calendar 2026 Q2

I want to back up a little bit and go into the academic and the government outlook. Is there pent-up demand there?

DemandRegulation PolicyTranscript · FY2026 Q2 →
Show response

Rainer declined a timeline, citing dependence on government policy; expects stability, notes academia is <5% of revenue; partial.

can we get a little bit of an early read on it? Would you be willing to give us maybe the growth rate

Show response

Rainer confirmed Masimo grew high single digits and highlighted a new 510(k) assay; direct.

Calendar 2026 Q1

Congrats. Can you talk about raw materials, just resins, cost?

Cost PressureSupply ChainMacroeconomicTranscript · FY2026 Q1 →
Show response

Blair said petrochemical-derivative pressure from oil price volatility has not been meaningful yet, citing DBS rigor and contract positions. On Middle East, no direct supply chain exposure but indirect oil price effects are being managed proactively through monthly P&L reviews.

Calendar 2025 Q4

have you seen a sizable reload as the cases have picked up

DemandRevenue GrowthTranscript · FY2025 Q4 →
Show response

ILI peaked at near-record highs in late Q4. Since declined but testing remains robust. Guiding Q1 respiratory at approximately $500M.

can you help us understand a little bit of the postmortem other than just the margin impact

Cost PressureMarginTranscript · FY2025 Q4 →
Show response

Rainer confirmed rooftop consolidation, process efficiency gains, and headcount reductions but declined to share specific numbers. Expects cost savings to sustain long-term.

Calendar 2025 Q3

Things seem to be more stable in the last couple of quarters. It's nice to see that

Revenue GrowthProduct LaunchTranscript · FY2025 Q3 →
Show response

Matt clarified the flat guide is respiratory only ($1.7B). Non-respiratory, where sexual health resides, expected to continue growing high-single to low-double-digits. Total Cepheid should grow in 2026.

Have they changed over the last few years, just given the tariff and cost inflation dynamics

PricingTrade TariffsTranscript · FY2025 Q3 →
Show response

Rainer confirmed more flexibility built into contracts over the years, particularly in bioprocessing where Danaher has leverage to drive differentiated pricing for differentiated solutions.

Calendar 2025 Q2

Is the structural cost out part of the story? Is that behind us now?

Cost PressureMarginTranscript · FY2025 Q2 →
Show response

Rainer confirmed about $75M of $150M structural cost savings captured, very comfortable and confident in achieving the full amount through the second half.

is this a case of where kind of, you know, AI spend is crowding out perhaps some of the opportunities

Show response

Rainer sees AI as tailwind, less spent on discovery, more on validated compounds progressing through development and manufacturing where Danaher has strongest position. Current activity low but stable.

Calendar 2025 Q1

Presumably assets have re-rated lower in the M&A world, although, we -- it's -- we don't have a lot of data points there yet

Capital AllocationM&ATranscript · FY2025 Q1 →
Show response

Matt drew historical parallels, after macro shocks, having balance sheet strength creates good buying opportunities. Rainer reiterated disciplined framework: attractive end market, outstanding asset, workable valuation.

how do you guys think about the algorithm of kind of long-term growth there versus kind of the reality that maybe the pricing environment

Geographic ExpansionPricingTranscript · FY2025 Q1 →
Show response

Rainer framed VBP as bringing China pricing closer to global levels, making it still an attractive long-term end market for Danaher's diagnostics businesses.

Calendar 2024 Q4

where does Abcam and Aldevron, however, you pronounce it,, where do they sit versus the deal model

Show response

Candid answer: Abcam tracking close to deal model, but Aldevron behind due to genomics end-markets taking longer to recover. Still view it as strategic must-own asset.

What does AI do for you guys at - it could be broader than just Cepheid

Cloud & AIInnovation & R&DTranscript · FY2024 Q4 →
Show response

Rainer described AI application across R&D to accelerate assay development, integrated evidence plans, and decision support systems. Cited Indica Labs partnership for AI-powered digital pathology.

JCIJohnson Controls13 questions · 8 reporting periods · 1 of 13 challenging
JCI company page →

Calendar 2026 Q2

How do the hyperscalers think about working with you guys and your peers?

Competitive DynamicsDemandTranscript · FY2026 Q3 →
Show response

CEO explained hyperscalers design-in two or three vendors and split awards, and said JCI is gaining share in its focus categories by executing on design, lead times, and service.

Calendar 2026 Q1

the 7 lighthouse sites projected in 2 years, I think you're starting with a couple of lighthouse sites now. How does that kind of

Innovation & R&DMarginTranscript · FY2026 Q2 →
Show response

Joakim clarified lighthouses are Olympic gold medal reference sites (not the only deployment locations), with ~7 covering commercial, manufacturing, and innovation.

the services order is still a little sluggish. Is there some timing issues there or any dynamic

DemandCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Joakim explained security service is less differentiated and needed price/volume rebalancing, while HVAC service remains solid. Directly addressed the weakness and its cause.

Calendar 2025 Q4

since you were there recently, you could just tell us what you're seeing on the ground because clearly we're seeing a broad set of different results

Geographic ExpansionDemandTranscript · FY2026 Q1 →
Show response

China stabilizing but unlikely to return to prior growth rates. Southeast Asia and India showing strength in data centers, healthcare, and pharma manufacturing.

the entrance into CDUs, is the goal here to kinda bundle this into a total solution that, you know, it I would imagine it's still a separate purchase order right now

Cloud & AICompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Today a mix of standalone CDU and combined offers. As thermal architectures evolve, CDUs complement chillers and air handling. Portfolio approach helps optimize for customers.

Calendar 2025 Q3

have you pretty much unwound any remaining matrix within the management, within the structure of the organization?

Competitive DynamicsCost PressureTranscript · FY2025 Q4 →
Show response

Work in progress. A few leadership tweaks since joining but no major structural moves yet. Building championship team to drive company transformation.

Have you changed compensation structures meaningfully down into the organization, Joakim?

Competitive DynamicsCost PressureTranscript · FY2025 Q4 →
Show response

Rolling out 9 enterprise KPIs throughout organization. Compensation largely intact with minor tweaks. Accountability framework more important than comp changes.

Calendar 2025 Q2

do you have a better sense, Joakim now of what the -- how you can accelerate growth in Fire & Security

Revenue GrowthCapital AllocationTranscript · FY2025 Q3 →
Show response

Acknowledged HVAC and F&S are fundamentally different businesses. Business system approaches will gradually deploy into F&S. Board working on portfolio conclusions.

Calendar 2025 Q1

Do you expect those value streams to kind of lead you down the path of SKU rationalization or is that a separate kind of hurdle?

Cost PressureSupply ChainTranscript · FY2025 Q2 →
Show response

SKU rationalization done together with value stream work. Separate exercise already started to attack low-hanging fruit on SKU proliferation.

how do you plan to kind of launch lean or deploy lean, I should say an organization this large?

Cost PressureCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Weidemanis described lean value-stream mapping approach, noted some lean remnants exist from automotive heritage. Already started slowly on one value stream.

Calendar 2024 Q4

has it changed over time, meaning are the orders a little bit longer duration now than they used to be?

DemandCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

Confirmed shift to longer-cycle orders driven by both market trends and JCI's strategic focus on higher-value verticals with service attachment.

I would have guessed maybe incrementals to be a little bit higher than 30%

ChallengingMarginPricingTranscript · FY2025 Q1 →
Show response

Two factors holding incrementals: FX headwind of $0.05 and tariff uncertainty limiting second-half margin expansion visibility.

Calendar 2024 Q3

how would you compare kind of the pricing power in that vertical to the traditional building segment?

PricingCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Marc said most Applied and data center work is engineered solutions where JCI's differentiation lets it command better pricing and margins than traditional equipment.

TTTrane Technologies13 questions · 7 reporting periods · 0 of 13 challenging
TT company page →

Calendar 2026 Q2

should we expect a little bit of improvement in incremental margins kind of going forward?

MarginPricingCost PressureTranscript · FY2026 Q2 →
Show response

Conceded price/cost is a headwind into the second half but sequentially improving, and flagged heavy Q2 investment.

did inventories get too low, did we overcorrect and now we need to correct up the other direction?

Show response

Answered directly; CFO added that year-to-date sell-in approximately equals sell-through.

Calendar 2026 Q1

are you guys operating full out in your factories and your applied facilities right now? Are you fully capacitized

Supply ChainCapex InvestmentTranscript · FY2026 Q1 →
Show response

Regnery confirmed capacity flex with most factories on 1-2 shifts. Kuehn noted CapEx raised to 2-3% of revenue for Florida/Texas expansions.

What particular markets -- I'm assuming that continued just given the orders up 160% has to be pretty broad-based

DemandCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Regnery confirmed broad-based growth across 9 of 14 verticals. Emphasized 95%+ of sales force doesn't call on data centers. Kuehn quantified $1.7-1.8B organic backlog growth.

Calendar 2025 Q4

whether orders are broadening out amongst your end markets, you know, like office education, etcetera, or are they narrowing and more of that incremental order strength is in fact data center

DemandCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

CEO confirmed 12 of 14 tracked verticals positive with broad-based growth. Noted retail and office returning to growth. Pipelines also broad-based across verticals.

Calendar 2025 Q3

Is that -- is there any of that, that's leaking into '27?

DemandRevenue GrowthTranscript · FY2025 Q3 →
Show response

CEO confirmed most backlog ships within 15 months. CFO noted expected orders for 2027 slots will convert starting Q4 into 2026 upon signed POs.

What's new in that design? It looked like to me, it almost implied that you guys are making the CDU

Innovation & R&DCapex InvestmentTranscript · FY2025 Q3 →
Show response

CEO declined specifics for competitive reasons but emphasized deep technical engineering collaboration with NVIDIA, noting innovations are being pulled back into core markets.

Calendar 2025 Q2

Has the entire market adjusted? I mean I know your U.S. competitors have followed suit with pricing terms and credit

CreditCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

CEO noted mixed competitor response but confirmed sequential improvement in China. Credit policy anniversary provides easier comps starting Q3 2025.

your incrementals sequentially went up from kind of 25% to 32%. Was that mostly just a mix?

MarginRevenue GrowthTranscript · FY2025 Q2 →
Show response

CFO attributed strong incrementals to services mix, factory productivity, and volume leverage. CEO emphasized continued high-level investment despite margin beat.

Calendar 2025 Q1

how has the market responded? Have others come in and been rational? Or have folks come in and kind of fill that white space

CreditCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

CEO noted sequential improvement in China credit implementation but did not directly address competitor behavior. Expects a couple more quarters to fully normalize.

are your contracts flexible enough to allow surcharges or other mitigation? How does that kind of logistically work?

Trade TariffsPricingTranscript · FY2025 Q1 →
Show response

CFO confirmed some applied contracts have tariff protections but not the majority. Emphasis on reducing dollar impact through supplier negotiations and trade route optimization.

Calendar 2024 Q4

Do you measure internally the number of energy audits that you do kind of each quarter? And is there such a thing as kind of thinking about that

DemandInnovation & R&DTranscript · FY2024 Q4 →
Show response

CEO confirmed they track energy audits as a leading metric but declined to disclose specifics, noting it is part of their operating system.

can you use AI now to do a digital twin meaningfully faster than you could in the past? Are we there?

Cloud & AIInnovation & R&DTranscript · FY2024 Q4 →
Show response

CEO confirmed AI is accelerating digital twin creation, combined with visual before-and-after demos that are compelling for customers.

Show 13 more companies
HONHoneywell International Inc.12 questions · 6 reporting periods · 1 of 12 challenging
HON company page →

Calendar 2026 Q2

can you just help us kind of size or at least help us understand the opportunity within the data center?

Show response

Vimal outlined three data center vectors: geographic build-out beyond the US, on-site power generation opening a Process Automation play, and liquid cooling sensing, targeting a higher share across Honeywell over time.

when you look at your M&A pipeline, is it kind of evenly split between your segments?

Show response

Vimal laid out three M&A buckets: strengthening IA sensing/measurement (top priority), adding to eight high-growth verticals, and smaller technology tuck-ins in fire detection and cybersecurity.

Calendar 2025 Q4

do you guys use a vitality index or anything internally and any kind of way to kinda compare the acceleration

Innovation & R&DRevenue GrowthTranscript · FY2025 Q4 →
Show response

4% of revenue from net-new products in 2025. Vitality index at ~45% for RemainCo but CEO now focuses on new metric: incremental revenue from genuinely new products. Target to maintain 4% rate.

I wanted to talk a little bit about price because forever Honeywell was kind of a 1% to 2% price company

Show response

Persistent inflation in labor (3-4%), electronics, and commodities supports structural 3-3.5% pricing. Differentiated by region and NPI. High-growth vertical migration enables better pricing. 2026 pricing similar to 2025.

Calendar 2025 Q3

you previously said that was kind of 1% to 2% tailwind accretion in '25, I believe, somewhere in that ballpark

Capital AllocationTranscript · FY2025 Q3 →
Show response

All acquisitions at ~12x multiple, at or ahead of TBA on revenue and cost synergies. Majority becoming organic growth starting Q4 2025. Technology fit reinforcing portfolio strategy.

I can't remember a quarter with 22% order growth. I know you gave some per segment granularity

DemandRevenue GrowthTranscript · FY2025 Q3 →
Show response

22% order growth was genuinely broad-based across all four segments. Long-cycle stronger than short-cycle but both growing. CEO expects Q4 trajectory to continue, foundation of two-year growth pivot.

Calendar 2025 Q2

I don't think I've ever seen a company prior to a breakup increase R&D spend

ChallengingInnovation & R&DTranscript · FY2025 Q2 →
Show response

CEO framed R&D acceleration as separate from separation, aimed at improving organic growth fundamentals. Moving from median to upper-quartile R&D spending.

what are the hurdles? Specifically, what are you guys looking for to be able to get that to an IPO-ready situation

Innovation & R&DCapital AllocationTranscript · FY2025 Q2 →
Show response

Quantinuum IPO timeline end of 2027 at latest, potentially earlier. Fundraise in progress. Qatar win validates commercial pipeline. Plans to be unveiled in Q4.

Calendar 2025 Q1

I just wanted to clarify kind of the cadence of, you know, you got the cost side of tariffs and you have price

Trade TariffsPricingTranscript · FY2025 Q1 →
Show response

Tariff mitigation to be on par by Q2 and fully stable by Q4. Team analyzing tariffs by HTS code with pricing and direct material productivity as key offset levers.

If there was a way to kind of rank it by segment, or give us a little color by segment of where the bigger impacts are

Show response

IA and Aerospace have largest tariff exposure. Building Automation nearly 100% local-for-local. ESS has some China demand risk. All contained in guidance.

Calendar 2024 Q4

What are you thinking timing to name the management teams of the pieces? And will there be an external search for aerospace

Capital AllocationTranscript · FY2024 Q4 →
Show response

Deferred specific naming timeline; indicated current leadership expected to continue. Board will decide leadership of RemainCo and Aerospace.

you've got $0.52 of below-the-line items and you've got $0.33 of profit contribution from M&A

Show response

Gave precise breakdown: $0.33 interest (M&A-driven), $0.10 repositioning, plus pension curtailment and corporate costs. Confirmed M&A net neutral in 2025.

CARRCarrier Global10 questions · 5 reporting periods · 0 of 10 challenging
CARR company page →

Calendar 2026 Q2

on the 75F, what are you buying here? You buying the technology? You buying an installed base

M&AInnovation & R&DTranscript · FY2026 Q2 →
Show response

Gitlin answered technology and talent first, citing 91 engineers, cloud-native agentic AI, wireless auto commissioning, and a complement to the ALC offering.

Can you go into a little bit more detail? Kind of the mix versus price cost, the challenges that you had there

MarginCost PressureTrade TariffsTranscript · FY2026 Q2 →
Show response

Goris itemized the drivers: tariff mitigation timing, lower JV income, Europe battery and solar mix, container versus truck trailer, and richer new construction mix in CSA.

Calendar 2026 Q1

Do you guys think we're close to a bottom in China? It's been kind of sloppy for a while

DemandGeographic ExpansionMacroeconomicTranscript · FY2026 Q1 →
Show response

Dave was candid that resi China shows no signs of turning but highlighted encouraging CHVAC verticals: data centers, EV battery, healthcare, semiconductor fab. CHVAC flattish in Q1.

I would imagine you're pretty much sold out on data center and applied for '26. So when you get a new order in, what you say, in the month of May

DemandCloud & AISupply ChainTranscript · FY2026 Q1 →
Show response

Dave confirmed they can still book and ship in 2026. Backlog covers $1.5B target. Already booking for 2027 with better quarterly distribution than 2026.

Calendar 2025 Q4

I'm sure it's not perfect, but I'm just trying to get a sense of that how that orders flows through through revenues

Cloud & AIRevenue GrowthTranscript · FY2025 Q4 →
Show response

Gitlin confirmed $1.5B data center revenue target for 2026 (~50% growth). Strong orders in Q4 and January. More deliveries weighted to March/April. Would like to see some pulled in but customers requesting those delivery dates.

how far below normal do you think channel inventories are in CSA resi?

Show response

Gitlin confirmed field inventory down ~32% YoY as of January, at 2018-type levels. Continued to take down through January. Targeted levels achieved.

Calendar 2025 Q3

does that impact your ability to get the price that you wanted to get for 2026

Show response

Gitlin confirmed mid-single-digit price increase announcement in coming weeks, expecting low single-digit realization. This year mix + price both ~10%, continuing in Q4. Next year price more modest than this year.

Is there actual structural cost out that we can count on lingering not just into '26, but going forward?

Cost PressureMarginTranscript · FY2025 Q3 →
Show response

Gitlin emphasized 3,000 indirect heads being removed structurally, not short-term squeeze. Using CBS organization for efficiency, AI in legal/back office, 20,000 Copilot licenses. Discipline on not adding heads back.

Calendar 2025 Q2

do you think about productivity kind of in traditional ways, like 2% per year, holding headcount flat?

Show response

Gitlin broke down targets: supply chain ~5%, logistics ~4%, factories ~3%, plus other levers. Net productivity 2-3% gross annually.

will we eventually see productivity on the gross margin line? Or is it more explicitly kind of SG&A productivity

MarginCost PressureTranscript · FY2025 Q2 →
Show response

Goris confirmed biggest opportunity is on gross margin line (materials, warehousing, logistics). Gitlin added: company was 10% ROS, now 19.1%. G&A went from 9%+ to ~7% of sales. Net productivity target 2-3% per year (supply chain ~5%, logistics ~4%, factories ~3%).

PHParker Hannifin10 questions · 6 reporting periods · 0 of 10 challenging
PH company page →

Calendar 2026 Q2

What are the final hurdles left to close the Filtration Group and CIRCOR? Any major hurdles?

Show response

Directly confirmed no major hurdles and reaffirmed both deals close in 2H calendar 2026, subject to customary regulatory clearances.

Calendar 2025 Q4

The time line you give to close Filtration Group kind of 6 to 12 months so you could drive a bus for that. But what are the major gating factors

Show response

Jenny confirmed only standard regulatory filings and processes are gating factors. No unusual antitrust or other hurdles mentioned beyond standard process.

is it an increasing -- are you able to drive price kind of in time? I know with -- in some of your products, it runs through distribution, that's less of a challenge sometimes

PricingCost PressureTranscript · FY2026 Q2 →
Show response

Jenny expressed strong confidence in pricing muscle developed over years. Todd reinforced by pointing to record margins across every business as evidence of cost and price management. Neither quantified specific pricing vs commodity impact.

Calendar 2025 Q3

it's been a few years since you closed Meggitt and, obviously, that's such a great deal for you guys. But Curtis seems like an interesting deal too

M&ACapital AllocationTranscript · FY2026 Q1 →
Show response

Jenny reiterated active pipeline with deals of all sizes, same strategic criteria. Prefers acquisitions but must be disciplined. Looking for companies where Parker is clear best owner.

Calendar 2025 Q2

I'm trying to kind of picture how 85 different P&Ls kind of manage something that's such a big, complex global issue

Trade TariffsPricingTranscript · FY2025 Q4 →
Show response

Jenny explained pricing leaders at division level with group/enterprise coordination. Teams using analytics and robust processes to navigate. Todd added global footprint and dual sourcing are also key, not just pricing.

Is that an indication that you expect M&A to continue to be more of kind of the smaller bolt-on type stuff? Or am I reading too much into that

M&ACapital AllocationTranscript · FY2025 Q4 →
Show response

Jenny reiterated pipeline has all sizes and timing is hard to predict. Todd noted 1.7x leverage (vs 2x target) provides significant capacity beyond the share repurchase.

Calendar 2025 Q1

M&A, just again, I know you still talk about having a pretty strong pipeline. But any additional color on what we might expect to see whether larger deals, mid-sized

M&ACapital AllocationTranscript · FY2025 Q3 →
Show response

Jenny said pipeline has targets of all sizes with active analysis and relationships, but timing is hard to predict. Todd added capacity has never been greater with $5B+ EBITDA.

is there any way to kind of tease out what kind of how much operational improvements have really helped you guys, even if you can't quantify it

MarginCost PressureTranscript · FY2025 Q3 →
Show response

Jenny attributed gains to Win Strategy tools and decentralized structure giving GMs better visibility and planning ability. Couldn't quantify operational vs mix split.

Calendar 2024 Q4

what do you see out there in the M&A environment? And is your enthusiasm or, I should say, confidence in getting deals done in higher than it was

M&ACapital AllocationTranscript · FY2025 Q2 →
Show response

Jenny described a robust M&A pipeline with targets of all sizes, emphasizing Parker's strong position after debt paydown and commitment to accretive deals.

Any kind of weird stuff out there as it relates to either buying ahead of tariffs or buying ahead of price increases or anything else

Trade TariffsDemandTranscript · FY2025 Q2 →
Show response

Jenny denied any pre-buying effects, attributing order improvement to genuine aerospace/defense and longer-cycle demand rather than tariff pull-forward.

XYLXylem Inc.10 questions · 5 reporting periods · 0 of 10 challenging
XYL company page →

Calendar 2026 Q2

just switching gears to M&A and potential things to do with your balance sheet,

M&ACapital AllocationTranscript · FY2026 Q2 →
Show response

Pine called it a mixed bag: private valuations starting to soften but generally not aligned to the public market. No multiples given; reiterated the $1 billion deployment goal and healthy funnel.

and I am just kind of curious to hear your view on how it evolves as it scales.

Cost PressureMarginTranscript · FY2026 Q2 →
Show response

Grogan confirmed this year is the peak of walkaway revenue at close to 2%, next year significantly lower. Framed 80/20 as shifting from a margin lever to a growth enabler in 2027.

Calendar 2025 Q4

Your balance sheet is starting to look a little bit too good.

Capital AllocationM&ATranscript · FY2025 Q4 →
Show response

Deployed ~$250M toward M&A in H2 2025, much more in process for 2026. Targeting ~$1B/year M&A deployment. Won't rule out transformational but focused on small-to-medium bolt-ons. At low leverage levels like now, will be much more active on buybacks.

there's a certain point where eighty-twenty goes from being a headwind to a tailwind, meaning that you're doing better with the customers that matter the most

Competitive DynamicsRevenue GrowthTranscript · FY2025 Q4 →
Show response

2026 is inflection point. Started in H2 2025, entering 2026 with momentum on growth engine. Building enterprise selling organization and Salesforce effectiveness. Goal: sales teams 75-80% customer-facing vs 30-40% today. Exit 2026 with growth momentum.

Calendar 2025 Q3

your net debt to EBITDA, 0.4x, I think you mentioned. The -- pegs the kind of question on priorities in the next 12 months.

Capital AllocationM&ATranscript · FY2025 Q3 →
Show response

Priorities: invest in core, M&A, dividends, opportunistic buybacks. Most actionable M&A funnel ever due to bottoms-up process. Focus on small-to-medium bolt-ons deploying ~$1B/year creating $60-75M EBITDA. Wouldn't rule out transformational if strategic.

you led in with culture, processes and structure. What do you specifically mean by structure?

Competitive DynamicsCost PressureTranscript · FY2025 Q3 →
Show response

Moved from matrix to 16 discrete division P&Ls with GM accountability. Delegation of authority went from 20-25 signers to 4-5. Enables faster decisions and better customer service.

Calendar 2025 Q1

the water solutions and service segment, is that is that a little bit too lumpy for us to start picking on quarters

Revenue GrowthDemandTranscript · FY2025 Q1 →
Show response

Confirmed lumpiness. Backlog up 6-7% YoY. Excluding tough $150M outsourced water comp, orders would have been extremely strong. Rolling 12-month view recommended.

balance sheet still really under levered and you've had a, you know, you've had a lot of market disruptions

M&ACapital AllocationTranscript · FY2025 Q1 →
Show response

Very active M&A funnel. Private valuations haven't moved yet. Portfolio optimization ongoing with more divestitures planned.

Calendar 2024 Q4

when you joined on-time deliveries was kind of -- went through kind of a dark day, had to get to the other side of it

Competitive DynamicsDemandTranscript · FY2024 Q4 →
Show response

Clear metrics: 500bp improvement in 2024, 500-700bp more to hit entitlement/best-in-class. Expects to come close this year.

Is it fair to assume that the 80/20 headwind is about two points. Does that sound kind of ballpark?

Revenue GrowthCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Confirmed 80/20 walkaway revenue headwind is slightly below 2 percentage points.

ETNEaton Corporation9 questions · 6 reporting periods · 1 of 9 challenging
ETN company page →

Calendar 2026 Q2

Paulo, I think you just crossed a year as CEO. Any reflections?

Capital AllocationM&ATranscript · FY2026 Q2 →
Show response

Paulo gave an extended strategy recap around the lead/invest/execute pillars, acquisitions, and the Mobility separation.

Calendar 2026 Q1

your competitive position in the landscape for solid-state transformers or on the medium voltage side

Cloud & AIInnovation & R&DTranscript · FY2026 Q1 →
Show response

Paulo gave an extensive answer covering 800-volt DC architecture, NVIDIA partnership for Vera Rubin, efficiency gains from AC to DC (93% to 98%), and pilots approaching 2 handful with hyperscalers. Expects orders H2 for shipments starting late 2027.

Calendar 2025 Q3

Where do we stand right now with channel inventories? Are they back to kind of more normal levels?

Supply ChainDemandTranscript · FY2025 Q3 →
Show response

Paulo confirmed resi at bottom, distributed IT recovered with double-digit order growth, and utilities showing very strong double-digit order growth.

Are you at the point where you may need to upsize that '26 CapEx number given the order book?

Capex InvestmentCapital AllocationTranscript · FY2025 Q3 →
Show response

Olivier confirmed 2026 will be peak CapEx year, returning to historical CapEx/revenue ratio from 2027, with current expansion plans being accelerated.

Calendar 2025 Q2

can you get to 40% gross margin once that capacity scales up and ERP spend kind of trails down

MarginGuidance ReliabilityTranscript · FY2025 Q2 →
Show response

Olivier confirmed close to 40% gross margin is in the plan with ramp included in second-half guide, consistent with 400bps operating margin expansion through 2030.

Calendar 2025 Q1

where are we now? I mean, I'm sure transformers are still a pretty long ways out

Supply ChainCapex InvestmentTranscript · FY2025 Q1 →
Show response

Paulo quantified lead time improvement at 20-25% but still above historical levels, with more capacity coming online in second half and early next year.

are you actually accelerating some plans to build local to local in light of the tariff announcements?

Capex InvestmentTrade TariffsTranscript · FY2025 Q1 →
Show response

Paulo clarified the $1.2B investment preceded tariffs, capacity is fungible across end markets, and focused on assembly with high output per dollar invested.

Calendar 2024 Q4

does it still make the same sense to have eMobility as a standalone segment today

ChallengingCompetitive DynamicsCapital AllocationTranscript · FY2024 Q4 →
Show response

Management defended separate reporting for transparency given different margin and growth profiles, while running operations with synergies internally.

the $900 million in CapEx, how much of that is growth versus maintenance?

Capex InvestmentCapital AllocationTranscript · FY2024 Q4 →
Show response

Olivier confirmed approximately 80% of $900M CapEx is growth-oriented with disciplined tail management.

FTVFortive9 questions · 6 reporting periods · 0 of 9 challenging
FTV company page →

Calendar 2026 Q2

are new products having a tangible impact on top line growth or sometimes see it in price

Innovation & R&DProduct LaunchRevenue GrowthTranscript · FY2026 Q2 →
Show response

Answered directly, tying the 6.7% core growth to the new product funnel and naming CertiFiber Max and ServiceChannel AI releases as examples.

are there limitations meaning particular businesses that you would not want to bolt-on to

M&ACapital AllocationCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Direct answer: no formal exclusions, but deals will skew toward Fluke and ASP and toward differentiated hardware over software.

Calendar 2025 Q4

what kind of a tailwind do you think bolt-ons are?

M&ACapital AllocationTranscript · FY2025 Q4 →
Show response

Hard to put a number on M&A tailwind given opportunistic nature. Value creation plan does not require dramatic M&A. Primary growth channel is organic via FBS-powered acceleration. Bolt-ons are smaller enhancements, not required for success.

is the $2.90 to $3.00 more a function of you feel like you've got that kind of visibility

Guidance ReliabilityTranscript · FY2025 Q4 →
Show response

Okerstrom cited business durability, improved forecasting, and 2025 share repurchase tailwind (~600bps to EPS net of interest). Good command on cost structure with G&A down, sales and marketing and R&D up. Recurring revenue profile adds comfort.

Calendar 2025 Q3

Can you get us up to speed on the outlook there and what you're seeing?

DemandRevenue GrowthTranscript · FY2025 Q3 →
Show response

Landauer continues strong growth driven by mission-critical radiation monitoring. Exploring add-on services to expand revenue from existing customer base of tens of thousands. Call cut off due to audio issues before full answer completed.

Calendar 2025 Q2

how big of a distraction was it to the organization with the spin and the management change kind of at the similar time

Capital AllocationTranscript · FY2025 Q2 →
Show response

Soroye acknowledged heavy workload but emphasized FBS culture meant operating companies had minimal disruption. Most spin activity on corporate team. Still delivered high end of EPS guide. Excitement about Fortive Accelerated strategy is high.

Calendar 2025 Q1

You mentioned localizing production. Just wanted to kind of explicitly understand what you mean by that

Trade TariffsSupply ChainTranscript · FY2025 Q1 →
Show response

Lico confirmed plans accelerate existing supply chain migration using contract manufacturing and current facilities, not new capacity builds.

how much of that business has just been kind of pushed to the right versus perhaps some real air pockets in demand there?

DemandRevenue GrowthTranscript · FY2025 Q1 →
Show response

Mostly delays not cancellations. Broad-based across all geographies including North America. Customers pausing on R&D investments. Semi recovery now pushed to 2026.

Calendar 2024 Q4

the the new realistic kinda long term growth rate are. I mean, we know what what you thought they were when you did the deals

DemandRevenue GrowthTranscript · FY2024 Q4 →
Show response

ASP guided to mid-single-digit growth from procedures, price, and innovation. Probation targeted at high-single to low-double from SaaS conversion and Apex Insights AI.

DOVDover Corporation8 questions · 6 reporting periods · 2 of 8 challenging
DOV company page →

Calendar 2026 Q2

Is the EPA mandate that pushing the CO2 stuff out to the right, is that changing anything for your customers?

Regulation PolicyDemandTranscript · FY2026 Q2 →
Show response

Richard said adoption is accelerating and the absence of a time-based mandate turns CO2 into a better multiyear opportunity for Dover.

Calendar 2025 Q4

what do you think the entitlement the new entitlement kinda through cycle growth rate is of this portfolio you have now?

Show response

Rich framed entitlement growth at 3-6% depending on GDP, with 5% clearly achievable, reflecting portfolio transformation toward higher-growth secular markets.

Calendar 2025 Q3

Can you guys give some context to your data center exposure and kind of terms maybe around content per megawatt or opportunity per megawatt?

Cloud & AIRevenue GrowthTranscript · FY2025 Q3 →
Show response

Rich reframed the question: Dover's focus is on spec wins with reference hyperscaler customers, not TAM modeling per megawatt; competitive stack is stable in both thermal connectors and heat exchangers.

Calendar 2025 Q2

what does that imply for the other 80%? And simple answer is always GDP, but not all our children can be above average

ChallengingRevenue GrowthCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Rich explained the other 80% isn't just GDP, Dover has been willingly shrinking lower-return portions to drive margin accretion; 4 of 5 growth platforms are organic (R&D-driven), not acquisition-dependent.

the portfolio itself, I don't think can drive 16% EPS growth forever without a healthy dose and velocity of M&A

ChallengingM&ACapital AllocationTranscript · FY2025 Q2 →
Show response

Rich disclosed $400M revenue under LOI with mostly proprietary deals, low execution risk; $50M highly likely near-term; capital deployment important for continued margin expansion.

Calendar 2025 Q1

would you be willing to share the actual growth rate in the thermal connectors? That you had in the quarter?

Cloud & AIRevenue GrowthTranscript · FY2025 Q1 →
Show response

Rich disclosed thermal connectors were up approximately 50% year-over-year (comparative growth, not sequential).

the other kind of second derivative of all this chaos is potentially M&A valuations getting a bit lower. Is that something you're kind of

M&ACapital AllocationTranscript · FY2025 Q1 →
Show response

Rich noted one meaningful multi-industrial transaction had robust valuation; some processes pulled due to uncertainty; Dover working on proprietary deals not in public domain.

Calendar 2024 Q4

is the refrigeration story just about CO2 in 2025? Or is it really also just about pent-up demand

DemandCapex InvestmentTranscript · FY2024 Q4 →
Show response

Rich confirmed pent-up demand thesis but noted Dover has capped retail refrigeration capacity; growth strategy focused on CO2 systems and specialty products plus productivity-driven margin gains.

TELTE Connectivity8 questions · 8 reporting periods · 1 of 8 challenging
TEL company page →

Calendar 2026 Q2

Can you talk a little bit about the ramp you expect in your FAU optical business?

Innovation & R&DCloud & AITranscript · FY2026 Q3 →
Show response

Terrence framed FAU/RAM Photonics optical as incremental TAM on top of copper, with meaningful revenue not until 2028 and beyond. Direct answer with timing.

Calendar 2026 Q1

the $150 million bump up, when does that get shipped out?

Cloud & AIRevenue GrowthTranscript · FY2026 Q2 →
Show response

Terrence confirmed $150M AI raise is entirely H2, mix of existing program ramps and new ramps. DDN AI revenue approaching $2.4B for FY2026. $2B of DDN orders in H1. Some lumpiness expected as programs ramp up and down. All businesses expected to grow from Q2 to Q3.

Calendar 2025 Q4

I just wanted to confirm that. But more importantly, I just wanted to address the scaling of those revenues. How is -- can you walk us through the kind of linkage between the capacity adds and the ...

Show response

Terrence confirmed $200M AI raise vs Investor Day. Growth across all hyperscaler customers. Some new awards in Q1 will ramp in Q3/Q4 and into FY27. Margins improving from AI volume leverage plus broad-based improvement across all Industrial businesses. On track toward $3B AI revenue target.

Calendar 2025 Q3

Can we mark-to-market that forecast? And just as importantly, where are you on kind of the scale impact there where you can get to or above kind of company average margins?

Show response

Terrence confirmed AI revenue tripled from $300M to $900M+. Suggested $600M of dollar growth this year as baseline for FY26. Also highlighted cloud non-AI doubling to $500M and enterprise/telecom growing double digits. DDN grew 80% organically for the quarter and the year.

Calendar 2025 Q2

is that business now fully ramped and scaled, meaning like profitability at or above company levels? How do you think about that?

Show response

Terrence confirmed AI margins slightly above Industrial segment average. Still in early innings with next-gen programs. Teams executing well scaling from $300M to $800M on cutting-edge products.

Calendar 2025 Q1

there's another kind of concern that people have, and that is an anti-American sentiment in the supply chain that perhaps certain regions may favor local suppliers

Trade TariffsCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Terrence emphasized localization insulates from anti-American sentiment. Clarified bulk of tariff exposure is in Industrial, not Transportation. Pricing surcharges primarily industrial.

Calendar 2024 Q4

how do you think about incremental leverage in TS when we get a recovery? Do you have costs that need to come back proportional to that recovery

Show response

Heath detailed structural cost reduction in Western Europe, footprint optimization. Commercial transport recovery will drive outsized leverage. Auto holding margins despite -3% decline.

Calendar 2024 Q3

Is there any visibility on when that business stabilizes? It seems to be kind of your toughest one right now

ChallengingDemandMacroeconomicTranscript · FY2024 Q4 →
Show response

Terrence acknowledged factory automation is bouncing around the bottom with Europe getting weaker, Americas stable, Asia slight improvement. Recovery likely not until calendar 2025.

VRTVertiv Holdings Co7 questions · 6 reporting periods · 0 of 7 challenging
VRT company page →

Calendar 2026 Q2

the timing shifts in 2Q revenues, the supply chain congestion comment. Can you give us a little bit more detail on that?

Supply ChainRevenue GrowthTranscript · FY2026 Q2 →
Show response

Gio acknowledged rising project complexity and framed it as a learning curve being worked through at speed; direct but no quantification.

Calendar 2026 Q1

Can you talk about the prefab market, like how important this market is? Or is there any way to think about a TAM?

Product LaunchDemandTranscript · FY2026 Q1 →
Show response

Gio explained prefab drives convergence into optimized systems like One Core SmartRun, and that it concentrates TAM opportunity for Vertiv since it is all Vertiv technology.

What kind of productivity levels can you run when you try -- I mean, you're adding capacity, obviously, quickly

MarginCapex InvestmentTranscript · FY2026 Q1 →
Show response

Gio deferred specifics to the upcoming Pelzer facility tour, noting manufacturing systems achieve higher productivity than piece-by-piece on-site assembly.

Calendar 2025 Q4

is there any incentive perhaps for folks to make an order before the end of the year in 2025 or price or otherwise or getting ahead in the queue

Show response

Confirmed no unusual dynamics or pre-buying incentives. Orders reflect genuine demand with customers knowing what they need, where and when. Large orders becoming normal market pattern. System-level thinking making orders bigger.

Calendar 2025 Q3

could you give us a little bit more color on perhaps the margin structure of services versus equipment, the growth rate

MarginCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Confirmed services are accretive overall with strong recurring revenue. Service growth lags equipment in hyper-growth periods but flywheel is accelerating. Higher density deployments conducive to service penetration.

Calendar 2025 Q2

can just talk a little bit about root cause. Are these the standard things of kind of premium freight and overtime labor

MarginSupply ChainTranscript · FY2025 Q2 →
Show response

Identified three overlapping factors: tariff-driven supply chain reconfiguration, 34% growth requiring capacity acceleration, and EMEA-specific execution challenges. All expected to normalize by year-end.

Calendar 2025 Q1

How do you see the mitigation efforts you know, from slide five? How do you see that phasing in through 2025

Trade TariffsPricingTranscript · FY2025 Q1 →
Show response

Explained countermeasures compound over time through two levers: pricing actions on new and existing backlog, and supply chain reconfiguration with inherent lag before benefits materialize.

EMREmerson Electric6 questions · 5 reporting periods · 1 of 6 challenging
EMR company page →

Calendar 2026 Q2

But what kind of lead times are you looking at now? Are you taking orders well into

DemandCapex InvestmentTranscript · FY2026 Q3 →
Show response

Lal confirmed Ovation lead times now extend into Q4 2027 and reach into 2028, signaling high visibility.

Calendar 2026 Q1

I do not think you mentioned why China was weak in the prepared remarks, but down 9% was pretty material

ChallengingMacroeconomicDemandTranscript · FY2026 Q2 →
Show response

CEO directly attributed China weakness to chemical overcapacity. Led to lowering full-year China from down low single digits to down mid-single digits.

we lost about a point in the Middle East, and it sounds like you expect to get about a half of that point back

Supply ChainGeographic ExpansionTranscript · FY2026 Q2 →
Show response

Management clarified $50M Q2 disruption with ~$100M expected in H2. Rebuild/restart opportunity of ~$100M over six quarters. Revenue not permanently lost.

Calendar 2025 Q4

on the opportunity out there in Venezuela and there's to be just a lot of old aging equipment in there that needs a refresh

Capex InvestmentDemandTranscript · FY2026 Q1 →
Show response

Karsanbhai cited approximately $1B of installed base with channel partners still intact. Not transacting since sanctions except sub-$1M/year with Chevron. Power generation likely first opportunity. Brain drain and security remain barriers but company is mobilized to act when laws enable foreign investment.

Calendar 2025 Q2

And are those installs profitable? I mean, how do you -- is it more of a loss leader and then you make money over time

MarginCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Both install and aftermarket are profitable, with aftermarket generating higher margins. Standard formula for control system business model.

Calendar 2025 Q1

What do you feel like you can do with the asset now that you fully control the outcome that you really couldn't do before?

M&AInnovation & R&DTranscript · FY2025 Q2 →
Show response

Key opportunity is driving ACV to sustained double-digit growth, accelerating technology roadmap for boundless automation, and cost synergies.

ITWIllinois Tool Works6 questions · 3 reporting periods · 1 of 6 challenging
ITW company page →

Calendar 2026 Q2

Give us a sense of how you measure it and how you kind of think about the contra account, meaning any cannibalization

Innovation & R&DProduct LaunchTranscript · FY2026 Q2 →
Show response

Precise definition given: audited, cannibalization netted out, three-year roll-off, and one of four compensated long-term metrics.

The M&A pipeline, have valuations come down at all? I know in some areas, they have and some they haven't.

M&ACapital AllocationTranscript · FY2026 Q2 →
Show response

Said valuations have not moved much and framed the posture as active but disciplined, citing MTS and a semi bolt-on as templates.

Calendar 2025 Q4

you didn't mention M&A at all in the prepared remarks. And is that kinda off the table for '26, or you didn't mention it just because it's more opportunistic?

Capital AllocationM&ATranscript · FY2025 Q4 →
Show response

Chris said actively prospecting but being disciplined on valuations. Recent bolt-on acquisition in semi-manufacturing space. Michael added challenging valuation environment means they won't do deals without reasonable risk-adjusted returns. $1.5B buyback contributes ~2% annual EPS growth.

up 18% and even up 9% patents are that's pretty big growth. Do you have to spend more to get to that 3%?

Innovation & R&DCapex InvestmentTranscript · FY2025 Q4 →
Show response

Chris said not about spending more, capabilities built over several years. It's about higher leadership focus, codified innovation framework launched in 2024, and ensuring consistently high practice quality across the company. CBI added to long-term incentive plans alongside margins, returns, and EPS growth.

Calendar 2024 Q4

I'm just kind of amazed that you can increase margins in a down volume environment. I mean, it just doesn't happen very often

MarginCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Michael explained margin expansion driven by enterprise initiatives (independent of volume) and higher-margin CBI products. PLS also contributes meaningfully.

what's holding you back on M&A? Is it price? Is it the opportunity set?

ChallengingM&ACapital AllocationTranscript · FY2024 Q4 →
Show response

Management said they're active in reviewing opportunities but very selective. Looking for 4%+ growth extension, business model leverage, and right valuation. MTS cited as successful example.

ROPRoper Technologies6 questions · 3 reporting periods · 0 of 6 challenging
ROP company page →

Calendar 2025 Q2

what do you think your core growth rate or kind of entitlement growth rate has changed kind of, I don't know, just say, 2022 to 2026

Revenue GrowthGuidance ReliabilityTranscript · FY2025 Q2 →
Show response

Neil said through-cycle organic improved from 6-6.5% to 7-7.5% with art of the possible in mid-8s. Growth-accretive acquisitions (CentralReach 30-40bps, Subsplash 15bps) provide hedge or stack.

are you assuming the Subsplash should be somewhere around segment average EBITDA margin year 5-ish

Show response

Management said Subsplash will reach low 40s EBITDA margins by year 5, below network segment average of mid-to-high 50s.

Calendar 2025 Q1

it sounds like tariffs are a big kind of nothing burger for you guys and seems somewhat isolated to Verathon. Is that a fair statement?

Trade TariffsSupply ChainTranscript · FY2025 Q1 →
Show response

Neil clarified tariff exposure across TEP segment, not just Verathon, but USMCA compliance limits total impact to $10-15 million.

The poor activity that we're seeing just seems like it could be hitting an air pocket, maybe in 2Q or later in 2Q

Supply ChainDemandTranscript · FY2025 Q1 →
Show response

Neil explained DAT carrier network doesn't flex immediately with short-term demand shifts. Would need 6-12 months of sustained weakness to impact. Assumed flat carrier volumes for year.

Calendar 2024 Q4

Would you consider issuing equity, Neil, if the opportunity set were wide enough, where it would make sense?

Capital AllocationM&ATranscript · FY2024 Q4 →
Show response

Neil said equity is possible but at a higher return and quality bar. Emphasized preference to deploy $5B balance sheet capacity first. Jason added PE metabolism will span 2025-2026.

do you guys think about that, like how that fill rate should be internal versus external or if there's some optimal

Labor MarketCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Neil described talent development progress with internal promotions (Brody to CEO, Stras to Frontline) reducing risk of external CEO hires by building bench depth.

VLTOVeralto4 questions · 2 reporting periods · 0 of 4 challenging
VLTO company page →

Calendar 2026 Q2

you guys in past quarters have kind of talked about this cost-out plan.

Cost PressureMarginTranscript · FY2026 Q2 →
Show response

CFO said savings are a few millions in Q4 and baked into the guide, with the biggest benefit in 2027, and confirmed market recovery has not slowed the program.

how we can think about the TAM in those businesses or opportunities or how big of a potential tailwind

DemandRevenue GrowthCloud & AITranscript · FY2026 Q2 →
Show response

CFO declined to quantify, saying Veralto is not public with that number yet; CEO offered ChemTreat strong double-digit growth as a proxy without sizing the TAM.

Calendar 2025 Q1

help us understand how the mechanics behind mitigation and kind of the timing and when you would expect to be fully offsetting the tariffs

Show response

CEO detailed three-pronged approach: pricing actions, manufacturing footprint shifts (Trojan Grand Rapids factory pulled forward 4 months), and supply chain sourcing changes. Emphasized asset-light model enables 6-month line moves.

have you seen anything in Videojet in April that would lead you to be a little bit concerned about the customer confidence

Show response

CEO confirmed no demand softening in April order patterns. Noted 4 consecutive quarters of equipment and consumables growth. IR VP added April order patterns still pretty normal.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
ROK Rockwell Automation150%none of 15 questions
MMM 3M Company147%1 of 14 questions
DD DuPont130%none of 13 questions
DHR Danaher Corporation130%none of 13 questions
JCI Johnson Controls138%1 of 13 questions
TT Trane Technologies130%none of 13 questions
HON Honeywell International Inc.128%1 of 12 questions
CARR Carrier Global100%none of 10 questions
PH Parker Hannifin100%none of 10 questions
XYL Xylem Inc.100%none of 10 questions
  • ROK
    Rockwell Automation · 15 questions
    0%none of 15 questions
  • MMM
    3M Company · 14 questions
    7%1 of 14 questions
  • DD
    DuPont · 13 questions
    0%none of 13 questions
  • DHR
    Danaher Corporation · 13 questions
    0%none of 13 questions
  • JCI
    Johnson Controls · 13 questions
    8%1 of 13 questions
  • TT
    Trane Technologies · 13 questions
    0%none of 13 questions
  • HON
    Honeywell International Inc. · 12 questions
    8%1 of 12 questions
  • CARR
    Carrier Global · 10 questions
    0%none of 10 questions
  • PH
    Parker Hannifin · 10 questions
    0%none of 10 questions
  • XYL
    Xylem Inc. · 10 questions
    0%none of 10 questions
Show all 19 companies
CompanyQuestionsChallenge rate
ETN Eaton Corporation911%1 of 9 questions
FTV Fortive90%none of 9 questions
DOV Dover Corporation825%2 of 8 questions
TEL TE Connectivity813%1 of 8 questions
VRT Vertiv Holdings Co70%none of 7 questions
EMR Emerson Electric617%1 of 6 questions
ITW Illinois Tool Works617%1 of 6 questions
ROP Roper Technologies60%none of 6 questions
VLTO Veralto40%none of 4 questions
  • ETN
    Eaton Corporation · 9 questions
    11%1 of 9 questions
  • FTV
    Fortive · 9 questions
    0%none of 9 questions
  • DOV
    Dover Corporation · 8 questions
    25%2 of 8 questions
  • TEL
    TE Connectivity · 8 questions
    13%1 of 8 questions
  • VRT
    Vertiv Holdings Co · 7 questions
    0%none of 7 questions
  • EMR
    Emerson Electric · 6 questions
    17%1 of 6 questions
  • ITW
    Illinois Tool Works · 6 questions
    17%1 of 6 questions
  • ROP
    Roper Technologies · 6 questions
    0%none of 6 questions
  • VLTO
    Veralto · 4 questions
    0%none of 4 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q3425%1 of 4 questions3
2024 Q42715%4 of 27 questions15
2025 Q1310%none of 31 questions17
2025 Q22512%3 of 25 questions16
2025 Q3250%none of 25 questions15
2025 Q4270%none of 27 questions16
2026 Q1195%1 of 19 questions11
2026 Q2280%none of 28 questions18
  1. 2024 Q34 questions · challenge rate 25% (1 of 4 questions) · 3 companies
  2. 2024 Q427 questions · challenge rate 15% (4 of 27 questions) · 15 companies
  3. 2025 Q131 questions · challenge rate 0% (none of 31 questions) · 17 companies
  4. 2025 Q225 questions · challenge rate 12% (3 of 25 questions) · 16 companies
  5. 2025 Q325 questions · challenge rate 0% (none of 25 questions) · 15 companies
  6. 2025 Q427 questions · challenge rate 0% (none of 27 questions) · 16 companies
  7. 2026 Q119 questions · challenge rate 5% (1 of 19 questions) · 11 companies
  8. 2026 Q228 questions · challenge rate 0% (none of 28 questions) · 18 companies

Topics

Topics tagged on this analyst’s questions.

  • Demand47
  • Competitive Dynamics34
  • Margin34
  • Revenue Growth30
  • M&A29
  • Capital Allocation28
  • Trade Tariffs21
  • Cost Pressure21
  • Cloud & AI19
  • Pricing19
Show all 21 topics
  • Innovation & R&D19
  • Capex Investment15
  • Supply Chain14
  • Inventory7
  • Geographic Expansion6
  • Product Launch6
  • Macroeconomic5
  • Guidance Reliability4
  • Regulation Policy2
  • Credit2
  • Labor Market1